Cargando…

Dexmedetomidine attenuates the propofol-induced long-term neurotoxicity in the developing brain of rats by enhancing the PI3K/Akt signaling pathway

BACKGROUND: Propofol induces short- and long-term neurotoxicity. Our previous study showed that dexmedetomidine (Dex) can attenuate the propofol-induced acute neurotoxicity in rodents by enhancing the PI3K/Akt signaling. However, whether treatment of young rats with Dex could protect them from long-...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yong, Zhou, Lifang, Tu, Youbing, Li, Yuantao, Liang, Yubing, Zhang, Xu, Lv, Jing, Zhong, Yu, Xie, Yubo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118247/
https://www.ncbi.nlm.nih.gov/pubmed/30214209
http://dx.doi.org/10.2147/NDT.S169099
_version_ 1783351893162983424
author Xiao, Yong
Zhou, Lifang
Tu, Youbing
Li, Yuantao
Liang, Yubing
Zhang, Xu
Lv, Jing
Zhong, Yu
Xie, Yubo
author_facet Xiao, Yong
Zhou, Lifang
Tu, Youbing
Li, Yuantao
Liang, Yubing
Zhang, Xu
Lv, Jing
Zhong, Yu
Xie, Yubo
author_sort Xiao, Yong
collection PubMed
description BACKGROUND: Propofol induces short- and long-term neurotoxicity. Our previous study showed that dexmedetomidine (Dex) can attenuate the propofol-induced acute neurotoxicity in rodents by enhancing the PI3K/Akt signaling. However, whether treatment of young rats with Dex could protect them from long-term neurotoxicity induced by propofol is unclear. MATERIALS AND METHODS: Seven-day-old male Sprague Dawley rats were randomized and injected intraperitoneally with saline (100 μL, NS), propofol (100 mg/kg), Dex (75 μg/kg), propofol (100 mg/kg) plus Dex (25, 50 or 75 μg/kg), 10% dimethyl sulfoxide (DMSO, 100 μL) or TDZD-8 (a GSK3β inhibitor, 1 mg/kg), or intracerebroventricularly with DMSO (5 μL) or LY294002 (a PI3K inhibitor, 25 μg/5 μL DMSO). Other rats in the experimental group were injected with the same doses of propofol, Dex and LY294002 or TDZD-8. All the rats were monitored until they were 9 weeks old. Their spatial learning and memory were tested by Morris water maze. The neuronal apoptosis, expression of PSD(95), expression and phosphorylation of Akt and GSK3β and synaptic ultrastructures were determined by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling, immunohistochemistry, Western blot and transmission electron microscopy assays, respectively. RESULTS: Compared with the NS control group, young rats injected with intralipid, Dex, TDZD-8, LY294002 or DMSO alone did not show any significant change as they aged. Propofol significantly increased the escape latency time, hippocampal neuroapoptosis and synaptic ultrastructural changes but decreased the relative levels of PSD(95) expression, and Akt and GSK3β phosphorylation in the developing hippocampus of the rats. The neuronal toxic effects of propofol were significantly mitigated by the pretreatment with a higher dose of Dex. The neuroprotective effect of Dex was enhanced by the treatment with TDZD-8, but was completely abrogated by the treatment with LY294002. CONCLUSION: Our results indicated that the pretreatment of young rats with Dex attenuated the propofol-induced long-term neurotoxicity in their developing hippocampus by enhancing the PI3K/Akt signaling.
format Online
Article
Text
id pubmed-6118247
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-61182472018-09-13 Dexmedetomidine attenuates the propofol-induced long-term neurotoxicity in the developing brain of rats by enhancing the PI3K/Akt signaling pathway Xiao, Yong Zhou, Lifang Tu, Youbing Li, Yuantao Liang, Yubing Zhang, Xu Lv, Jing Zhong, Yu Xie, Yubo Neuropsychiatr Dis Treat Original Research BACKGROUND: Propofol induces short- and long-term neurotoxicity. Our previous study showed that dexmedetomidine (Dex) can attenuate the propofol-induced acute neurotoxicity in rodents by enhancing the PI3K/Akt signaling. However, whether treatment of young rats with Dex could protect them from long-term neurotoxicity induced by propofol is unclear. MATERIALS AND METHODS: Seven-day-old male Sprague Dawley rats were randomized and injected intraperitoneally with saline (100 μL, NS), propofol (100 mg/kg), Dex (75 μg/kg), propofol (100 mg/kg) plus Dex (25, 50 or 75 μg/kg), 10% dimethyl sulfoxide (DMSO, 100 μL) or TDZD-8 (a GSK3β inhibitor, 1 mg/kg), or intracerebroventricularly with DMSO (5 μL) or LY294002 (a PI3K inhibitor, 25 μg/5 μL DMSO). Other rats in the experimental group were injected with the same doses of propofol, Dex and LY294002 or TDZD-8. All the rats were monitored until they were 9 weeks old. Their spatial learning and memory were tested by Morris water maze. The neuronal apoptosis, expression of PSD(95), expression and phosphorylation of Akt and GSK3β and synaptic ultrastructures were determined by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling, immunohistochemistry, Western blot and transmission electron microscopy assays, respectively. RESULTS: Compared with the NS control group, young rats injected with intralipid, Dex, TDZD-8, LY294002 or DMSO alone did not show any significant change as they aged. Propofol significantly increased the escape latency time, hippocampal neuroapoptosis and synaptic ultrastructural changes but decreased the relative levels of PSD(95) expression, and Akt and GSK3β phosphorylation in the developing hippocampus of the rats. The neuronal toxic effects of propofol were significantly mitigated by the pretreatment with a higher dose of Dex. The neuroprotective effect of Dex was enhanced by the treatment with TDZD-8, but was completely abrogated by the treatment with LY294002. CONCLUSION: Our results indicated that the pretreatment of young rats with Dex attenuated the propofol-induced long-term neurotoxicity in their developing hippocampus by enhancing the PI3K/Akt signaling. Dove Medical Press 2018-08-28 /pmc/articles/PMC6118247/ /pubmed/30214209 http://dx.doi.org/10.2147/NDT.S169099 Text en © 2018 Xiao et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Xiao, Yong
Zhou, Lifang
Tu, Youbing
Li, Yuantao
Liang, Yubing
Zhang, Xu
Lv, Jing
Zhong, Yu
Xie, Yubo
Dexmedetomidine attenuates the propofol-induced long-term neurotoxicity in the developing brain of rats by enhancing the PI3K/Akt signaling pathway
title Dexmedetomidine attenuates the propofol-induced long-term neurotoxicity in the developing brain of rats by enhancing the PI3K/Akt signaling pathway
title_full Dexmedetomidine attenuates the propofol-induced long-term neurotoxicity in the developing brain of rats by enhancing the PI3K/Akt signaling pathway
title_fullStr Dexmedetomidine attenuates the propofol-induced long-term neurotoxicity in the developing brain of rats by enhancing the PI3K/Akt signaling pathway
title_full_unstemmed Dexmedetomidine attenuates the propofol-induced long-term neurotoxicity in the developing brain of rats by enhancing the PI3K/Akt signaling pathway
title_short Dexmedetomidine attenuates the propofol-induced long-term neurotoxicity in the developing brain of rats by enhancing the PI3K/Akt signaling pathway
title_sort dexmedetomidine attenuates the propofol-induced long-term neurotoxicity in the developing brain of rats by enhancing the pi3k/akt signaling pathway
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118247/
https://www.ncbi.nlm.nih.gov/pubmed/30214209
http://dx.doi.org/10.2147/NDT.S169099
work_keys_str_mv AT xiaoyong dexmedetomidineattenuatesthepropofolinducedlongtermneurotoxicityinthedevelopingbrainofratsbyenhancingthepi3kaktsignalingpathway
AT zhoulifang dexmedetomidineattenuatesthepropofolinducedlongtermneurotoxicityinthedevelopingbrainofratsbyenhancingthepi3kaktsignalingpathway
AT tuyoubing dexmedetomidineattenuatesthepropofolinducedlongtermneurotoxicityinthedevelopingbrainofratsbyenhancingthepi3kaktsignalingpathway
AT liyuantao dexmedetomidineattenuatesthepropofolinducedlongtermneurotoxicityinthedevelopingbrainofratsbyenhancingthepi3kaktsignalingpathway
AT liangyubing dexmedetomidineattenuatesthepropofolinducedlongtermneurotoxicityinthedevelopingbrainofratsbyenhancingthepi3kaktsignalingpathway
AT zhangxu dexmedetomidineattenuatesthepropofolinducedlongtermneurotoxicityinthedevelopingbrainofratsbyenhancingthepi3kaktsignalingpathway
AT lvjing dexmedetomidineattenuatesthepropofolinducedlongtermneurotoxicityinthedevelopingbrainofratsbyenhancingthepi3kaktsignalingpathway
AT zhongyu dexmedetomidineattenuatesthepropofolinducedlongtermneurotoxicityinthedevelopingbrainofratsbyenhancingthepi3kaktsignalingpathway
AT xieyubo dexmedetomidineattenuatesthepropofolinducedlongtermneurotoxicityinthedevelopingbrainofratsbyenhancingthepi3kaktsignalingpathway